Cargando…

Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques

Detalles Bibliográficos
Autores principales: Liu, Xiaolei, Liu, Yi, Jin, Xuemin, He, Zhanlong, Huang, Zhen, Sun, Shumin, Gao, Yuwei, Li, Jingyu, Ning, Qin, Xie, Zhongping, Jin, Ningyi, Liu, Mingyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261890/
https://www.ncbi.nlm.nih.gov/pubmed/35798694
http://dx.doi.org/10.1038/s41392-022-01095-8
_version_ 1784742379915313152
author Liu, Xiaolei
Liu, Yi
Jin, Xuemin
He, Zhanlong
Huang, Zhen
Sun, Shumin
Gao, Yuwei
Li, Jingyu
Ning, Qin
Xie, Zhongping
Jin, Ningyi
Liu, Mingyuan
author_facet Liu, Xiaolei
Liu, Yi
Jin, Xuemin
He, Zhanlong
Huang, Zhen
Sun, Shumin
Gao, Yuwei
Li, Jingyu
Ning, Qin
Xie, Zhongping
Jin, Ningyi
Liu, Mingyuan
author_sort Liu, Xiaolei
collection PubMed
description
format Online
Article
Text
id pubmed-9261890
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92618902022-07-08 Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques Liu, Xiaolei Liu, Yi Jin, Xuemin He, Zhanlong Huang, Zhen Sun, Shumin Gao, Yuwei Li, Jingyu Ning, Qin Xie, Zhongping Jin, Ningyi Liu, Mingyuan Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-07-07 /pmc/articles/PMC9261890/ /pubmed/35798694 http://dx.doi.org/10.1038/s41392-022-01095-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Liu, Xiaolei
Liu, Yi
Jin, Xuemin
He, Zhanlong
Huang, Zhen
Sun, Shumin
Gao, Yuwei
Li, Jingyu
Ning, Qin
Xie, Zhongping
Jin, Ningyi
Liu, Mingyuan
Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques
title Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques
title_full Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques
title_fullStr Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques
title_full_unstemmed Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques
title_short Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques
title_sort rapidly developable therapeutic-grade equine immunoglobulin against the sars-cov-2 infection in rhesus macaques
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261890/
https://www.ncbi.nlm.nih.gov/pubmed/35798694
http://dx.doi.org/10.1038/s41392-022-01095-8
work_keys_str_mv AT liuxiaolei rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT liuyi rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT jinxuemin rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT hezhanlong rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT huangzhen rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT sunshumin rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT gaoyuwei rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT lijingyu rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT ningqin rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT xiezhongping rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT jinningyi rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques
AT liumingyuan rapidlydevelopabletherapeuticgradeequineimmunoglobulinagainstthesarscov2infectioninrhesusmacaques